Page 10 - Immunizations News Today

BioNTech, like all Covid-19 vaccine makers, has gotten crunched in 2023. But it has so much cash that it would have appealed to Warren Buffett’s mentor,...

Voters are not enthusiastic about a Biden-Trump rematch, and alternatives like Kennedy or the No Labels third-party movement, which would typically be longshots, see an opening

The rapidly growing JN.1 coronavirus subvariant is now responsible for approximately one-third of new COVID-19 infections in the Northeast U.S., compared to about 20% of new infections across the country

FILE - Opponents of a bill to repeal Connecticuts religious exemption for required school vaccinations march down Capitol Avenue before the State Senate voted on legislation on April 27, 2021,

Vaccinations were stopped after it became clear they would not be effective. "We cannot and will not lose hope that the world will have an effective HIV vaccine," the International AIDS director said.

The company is pulling back on some of its research programs and laying off workers after overestimating pandemic-product sales

By Will Feuer Shares of Moderna and other makers of Covid-19 vaccines were dragged lower after rival Pfizer warned that it expects revenue from its Covid-19...

AstraZeneca agreed to acquire respiratory vaccine developer Icosavax in a cash deal expected to close in the first quarter of next year.

AstraZeneca agreed to acquire respiratory vaccine developer Icosavax in a cash deal expected to close in the first quarter of next year.

Jason Schrum’s work helped lay the foundation for Moderna’s Covid vaccine, but he hasn’t won any prizes or royalties and left the company after disagreements